You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 cell |
|---|---|
| Target | Cytotoxic T-lymphocyte protein 4 |
| Tag | C-His |
| Endotoxins | < 1.0 EU/μg as determined by LAL |
| MW | Due to glycosylation, the protein migrates to 28-35 kDa based on Tris-Bis PAGE result. kDa |
| Purity | > 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC |
| Protein Sequence | 36-161/223 |
Storage & Handling
−| Storage | Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
|---|---|
| Concentration | > 0.5 mg/ml |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Recombinant human CD86 / B7-2 protein, C-His-Avi (HEK293) [orb1516532]
> 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC
Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result. kDa
50 μg, 100 μgRecombinant human CTLA4 protein, C-His-Avi (HEK293), Biotin conjugated [orb2328761]
> 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC
Due to glycosylation, the protein migrates to 25-30 kDa based on Tris-Bis PAGE result. kDa
20 μgRecombinant human CD86 / B7-2 protein, C-His-Avi (HEK293), Biotin conjugated [orb2328775]
> 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC
Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result. kDa
20 μg, 100 μgRecombinant human CD86 protein, C-His (HEK293) [orb1808143]
> 90% as determined by SDS-PAGE
25.7 kDa
500 μg, 100 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].










